Provided by Tiger Trade Technology Pte. Ltd.

Emergent BioSolutions

5.08
+0.26005.39%
Post-market: 5.02-0.0620-1.22%19:52 EDT
Volume:1.42M
Turnover:7.05M
Market Cap:260.47M
PE:-1.50
High:5.11
Open:4.79
Low:4.75
Close:4.82
52wk High:14.06
52wk Low:4.36
Shares:51.27M
Float Shares:48.37M
Volume Ratio:1.26
T/O Rate:2.93%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.3870
EPS(LYR):0.9300
ROE:-40.29%
ROA:6.93%
PB:0.76
PE(LYR):5.46

Loading ...

Emergent BioSolutions Outlook FY Adjusted Net Income USD 45-65 Million

THOMSON REUTERS
·
May 01

Emergent BioSolutions Q1 Gross Margin 41%

THOMSON REUTERS
·
May 01

Emergent BioSolutions receives Singapore regulatory approval for ACAM2000

TIPRANKS
·
Apr 30

BRIEF-Emergent Biosolutions Receives Approval From Singapore Health Sciences Authority

Reuters
·
Apr 30

Singapore HSA approves Emergent ACAM2000 vaccine label expansion to include mpox

Reuters
·
Apr 30

Emergent BioSolutions shareholders approved amendment to increase stock incentive plan shares

Reuters
·
Apr 30

Emergent BioSolutions Inc: Executed Agreement Is Valued at Approximately $50 Mln

THOMSON REUTERS
·
Apr 29

Emergent BioSolutions Inc - Executed Agreement Is Valued at Approximately $50 Mln

THOMSON REUTERS
·
Apr 29

Emergent BioSolutions: Under Terms, Co to Provide End-to-End Development, Manufacturing Services to SAB Bio

THOMSON REUTERS
·
Apr 29

Emergent BioSolutions Secures Long-Term Strategic Manufacturing Contract with SAB Biotherapeutics to Advance Type 1 Diabetes Candidate, SAB-142

GlobeNewswire
·
Apr 29

Emergent BioSolutions Partners with Professional Baseball Player Davis Schneider to Raise Awareness of NARCAN® Nasal Spray Among Canadians and Help Save Lives

GlobeNewswire
·
Apr 29

H.C. Wainwright Remains a Buy on Emergent Biosolutions (EBS)

TIPRANKS
·
Apr 29

Emergent BioSolutions reports Imojev manufacturing pact with Substipharm

TIPRANKS
·
Apr 28

Emergent BioSolutions Inc - Enters $34.5 Mln Agreement With Substipharm for JE Vaccine Manufacturing and U.S. Distribution

THOMSON REUTERS
·
Apr 28

Emergent BioSolutions Inc - to Be Exclusive Distributor of JE Vaccine to U.S. Government Upon FDA Approval

THOMSON REUTERS
·
Apr 28

Emergent BioSolutions Inc - Canton Facility to Manufacture Drug Substance and Obtain Exclusive Distribution Rights

THOMSON REUTERS
·
Apr 28

Emergent BioSolutions and Substipharm Biologics Announce Strategic Manufacturing Partnership to Support Japanese Encephalitis Vaccine in the United States

GlobeNewswire
·
Apr 28

Emergent BioSolutions schedules first-quarter results conference call

Reuters
·
Apr 17

Emergent BioSolutions Inc - Amends Asset-Based Revolving Loan Facility With Wells Fargo to $50 Mln

THOMSON REUTERS
·
Apr 17

Emergent BioSolutions Inc - Closes New $150 Mln Term Loan With Orbimed

THOMSON REUTERS
·
Apr 17